#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Career

What you can contribute

Invest

How you can participate

Highlights

DDin - Evotec and Secarna

Collaboration on ASO drug discovery

Download

DDup TargetRD

iPSC-based retinal disease drug discovery

Download

Company presentation

October 2020

Download

Webcast

Collaborating and innovating in the search for new Anti-Infectives

Link

Fight against the most lethal cancers

Multiomics webinar - Evotec & Indivumed

Link

Drug Abuse Liability Assessment

White Paper

Link

Overcoming CMC challenges

in Rare Disease drug development and registration

Link

Webcast series

Drug Abuse Liability Assessment

Link

Webcast

INDiGO – the fastest path to the clinic

Link

News View all news

Just - Evotec Biologics receives grant to enable an antibody product for the prevention of COVID-19

Hamburg, Germany, 19 Oct 2020

Evotec SE today announced that its Seattle-based subsidiary, Just – Evotec Biologics, Inc., received a grant from the Bill &...

Read more

Topas Therapeutics Raises € 22 m (~US$ 26 m) in Series B Financing and appoints Klaus Martin, Ph.D. as Chief Executive Officer

Hamburg, Germany, 19 Oct 2020

Topas Therapeutics GmbH, a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction...

Read more

Business Dev Events View all events

26 October2020

29 October2020

BioEurope 2020 Venue: Digital event

24 October2020

25 October2020

32nd AACR-NCI-EORTC Symposium Venue: Digital event

Investor Relations Events View all events

3 November2020

ICF Bank Small-/Midcap-Konferenz Venue: Düsseldorf, Germany
Organisers: ICF Bank

12 November2020

Quarterly Statement 9M 2020

TOP